Centre for osteoarthritis pathogenesis Versus Arthritis
In plain English
AI plain-English summaryOsteoarthritis researchers at the Kennedy Institute in Oxford have identified specific molecules and biological pathways that drive the disease, and they now plan to work out exactly how those mechanisms cause joint damage. Osteoarthritis (OA) affects millions of people in the UK, causing pain, stiffness, and reduced mobility. There are currently no drugs that can slow or stop the disease—only pain relief and joint replacement surgery at the end stage. This gap exists because the fundamental biology of OA remains poorly understood. The researchers have already found several promising molecular targets, but they do not yet know how these molecules control the disease process. Over the next five years, the team will dissect the molecular mechanisms behind these pathways. They will also test their findings in patient tissue samples and early-stage clinical studies, and build a national network for discovering biomarkers—biological signals that could indicate early disease or track progression. If successful, this work could lead to the first disease-modifying treatments for osteoarthritis, potentially delaying or preventing the need for joint replacement surgery. It could also produce diagnostic tools that catch the disease earlier, when intervention is more likely to work.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
ZZZ-Centre of Excellence FullPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know